Correlation Between Ikena Oncology and Pmv Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Ikena Oncology and Pmv Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ikena Oncology and Pmv Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ikena Oncology and Pmv Pharmaceuticals, you can compare the effects of market volatilities on Ikena Oncology and Pmv Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ikena Oncology with a short position of Pmv Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ikena Oncology and Pmv Pharmaceuticals.
Diversification Opportunities for Ikena Oncology and Pmv Pharmaceuticals
0.9 | Correlation Coefficient |
Almost no diversification
The 3 months correlation between Ikena and Pmv is 0.9. Overlapping area represents the amount of risk that can be diversified away by holding Ikena Oncology and Pmv Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pmv Pharmaceuticals and Ikena Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ikena Oncology are associated (or correlated) with Pmv Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pmv Pharmaceuticals has no effect on the direction of Ikena Oncology i.e., Ikena Oncology and Pmv Pharmaceuticals go up and down completely randomly.
Pair Corralation between Ikena Oncology and Pmv Pharmaceuticals
Given the investment horizon of 90 days Ikena Oncology is expected to under-perform the Pmv Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Ikena Oncology is 1.42 times less risky than Pmv Pharmaceuticals. The stock trades about -0.27 of its potential returns per unit of risk. The Pmv Pharmaceuticals is currently generating about -0.13 of returns per unit of risk over similar time horizon. If you would invest 153.00 in Pmv Pharmaceuticals on November 3, 2024 and sell it today you would lose (11.00) from holding Pmv Pharmaceuticals or give up 7.19% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Ikena Oncology vs. Pmv Pharmaceuticals
Performance |
| Timeline |
| Ikena Oncology |
| Pmv Pharmaceuticals |
Ikena Oncology and Pmv Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ikena Oncology and Pmv Pharmaceuticals
The main advantage of trading using opposite Ikena Oncology and Pmv Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ikena Oncology position performs unexpectedly, Pmv Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pmv Pharmaceuticals will offset losses from the drop in Pmv Pharmaceuticals' long position.| Ikena Oncology vs. Edgewise Therapeutics | Ikena Oncology vs. Design Therapeutics | Ikena Oncology vs. Xilio Development | Ikena Oncology vs. Monte Rosa Therapeutics |
| Pmv Pharmaceuticals vs. MediciNova | Pmv Pharmaceuticals vs. Pharvaris BV | Pmv Pharmaceuticals vs. PepGen | Pmv Pharmaceuticals vs. Anebulo Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |